Atrial development in the human heart: an immunohistochemical study with emphasis on the role of mesenchymal tissues.
The development of the atrial chambers in the human heart was investigated immunohistochemically using a set of previously described antibodies. This set included the monoclonal antibody 249-9G9, which enabled us to discriminate the endocardial cushion-derived mesenchymal tissues from those derived from extracardiac splanchnic mesoderm, and a monoclonal antibody recognizing the B isoform of creatine kinase, which allowed us to distinguish the right atrial myocardium from the left. The expression patterns obtained with these antibodies, combined with additional histological information derived from the serial sections, permitted us to describe in detail the morphogenetic events involved in the development of the primary atrial septum (septum primum) and the pulmonary vein in human embryos from Carnegie stage 14 onward. The level of expression of creatine kinase B (CK-B) was found to be consistently higher in the left atrial myocardium than in the right, with a sharp boundary between high and low expression located between the primary septum and the left venous valve indicating that the primary septum is part of the left atrial gene-expression domain. This expression pattern of CK-B is reminiscent of that of the homeobox gene Pitx2, which has recently been shown to be important for atrial septation in the mouse. This study also demonstrates a poorly appreciated role of the dorsal mesocardium in cardiac development. From the earliest stage investigated onward, the mesenchyme of the dorsal mesocardium protrudes into the dorsal wall of the primary atrial segment. This dorsal mesenchymal protrusion is continuous with a mesenchymal cap on the leading edge of the primary atrial septum. Neither the mesenchymal tissues of the dorsal protrusion nor the mesenchymal cap on the edge of the primary septum expressed the endocardial tissue antigen recognized by 249-9G9 at any of the stages investigated. The developing pulmonary vein uses the dorsal mesocardium as a conduit to reach the primary atrial segment. Initially, the pulmonary pit, which will becomes the portal of entry for the pulmonary vein, is located along the midline, flanked by two myocardial ridges. As development progresses, tissue remodeling results in the incorporation of the portal of entry of the pulmonary vein in left atrial myocardium, which is recognized because of its high level of creatine. Closure of the primary atrial foramen by the primary atrial septum occurs as a consequence of the fusion of these mesenchymal structures.
Wessels
A
A
Department of Cell Biology and Anatomy, Medical University of South Carolina, Charleston 29425, USA. wesselsa@musc.edu
Anderson
R H
RH
Markwald
R R
RR
Webb
S
S
Brown
N A
NA
Viragh
S
S
Moorman
A F
AF
Lamers
W H
WH
D000911:Antibodies, Monoclonal; D003402:Creatine Kinase / Q000378:metabolism; D004622:Embryo, Mammalian / Q000196:embryology* / Q000201:enzymology; D006325:Heart Atria / Q000196:embryology* / Q000201:enzymology; D006801:Humans; D007124:Immunoenzyme Techniques; D007527:Isoenzymes; D008648:Mesoderm / Q000166:cytology* / Q000201:enzymology; D009206:Myocardium / Q000201:enzymology; D011667:Pulmonary Veins / Q000196:embryology
D000911:Antibodies, Monoclonal; D007527:Isoenzymes; D003402:Creatine Kinase